Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Astellas to Acquire US Gene Therapy Venture Audentes

Filed Under: Pharma Tagged With: , , , ,

Astellas Pharma Inc. (TYO:4503) recently announced that it has agreed to acquire Audentes Therapeutics Inc., a U.S.-based venture specializing in…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

AGC Looks to Advance Into Gene and Cell Therapy Business With Tender Offer for MolMed
AGC Looks to Advance Into Gene and Cell Therapy Business…
AGC in Race to Bolster CDMO Operations Across US, Europe and Japan
AGC in Race to Bolster CDMO Operations Across US, Europe and…
Overview of Major M&A Projects Under Japanese Chemical Companies in 2019
Overview of Major M&A Projects Under Japanese Chemical…
AGC Plans to Invest Over 200B Yen in CDMO Operations for Gene & Cell Therapy, More
AGC Plans to Invest Over 200B Yen in CDMO Operations for…
India Moves to Shed Dependence on China for Active Pharmaceutical Ingredients
India Moves to Shed Dependence on China for Active…
Evonik Plans Further Investment in mRNA Field to Expand Applications Beyond COVID-19 Vaccine
Evonik Plans Further Investment in mRNA Field to Expand…